Apoptosis
Apoptosis, also known as programmed cell death, is rigorously controlled process of cell death that leads to phagocytosis of unwanted cell. It is triggered after sufficient cellular damage and activated through extrinsic or intrinsic pathways. The intrinsic pathway is mainly occurs via release of cytochrome c from the mitochondria and regulates mitochondrial outer membrane permeabilization by Bcl-2 family proteins. The extrinsic pathway is induced by ligand binding to death receptor, such as Fas, TNFαR, DR3, DR4, and DR5. Caspases then cleave target proteins and nuclear lamins to promote DNA degradation, resulting apoptotic cells undergo phagocytosis. In addition, p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.
Some Inhibitors of apoptosis proteins (IAPs), such as XIAP/BIRC4 and Bruce/BIRC6, can block casapse activity through direct binding, while other IAPs, such as cIAP1/BIRC2, cIAP2/BIRC3, act as ubiquitin ligases that target caspases for ubiquitin-mediated degradation. Apoptosis is essential for growth, development and aging in multicellular organisms. Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases, including cancer.
-
BA3559 EpisappanolSummary: Episappanol is a natural compound. -
BA3560 EvunzekibartSummary: Evunzekibart (ATOR-1017) is a conditional agonist and type 1 antibody to the Fc-γ receptor. -
BA3561 CAY10789Summary: CAY10789 is a potent antagonist (=2.80 μM) and agonist (=3 μM). -
BA3562 BML-280Summary: BML-280 (VU0285655-1) is a potent and selective phospholipase D2 inhibitor. -
BA3563 NegleteinSummary: Negletein is a neuroprotective agent that enhances the action of nerve growth factor and induces outward growth of neurites in PC12 cells. -
BA3564 ExlinkibartSummary: Exlinkibart (LVGN-6051) targets TNFRSF9. -
BA3565 EJMC-1Summary: EJMC-1 is a moderately potent inhibitor. -
BA3566 RemtolumabSummary: Remtolumab (ABT-122) is a bivariate domain immunoglobulin. -
BA3567 IratumumabSummary: Iratumumab (MDX-060) is a human IgG1κ monoclonal antibody against... -
BA3568 TecaginlimabSummary: Tecaginlimab (BNT-312) is an Fc-inert bispecific antibody.


